Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis

Journal of Biological Chemistry

Volumn 288, Issue 42, 2013, Pages 30105-30113

  Ma, Yun ^a,b   Krueger, Jessica J ^c   Redmon, Sara N ^c   Uppuganti, Sasidhar ^b,d   Nyman, Jeffry S ^b,d,e   Hahn, Maureen K ^b,c,d   Elefteriou, Florent ^a,b,d  

^a Division of Clinical Pharmacology   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Division of Genetic Medicine   (United States)

^d Department of Pharmacology ^*  (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE HOMEOSTASIS; BONE REMODELING; BONE-FORMING CELLS; EXTRACELLULAR; FRACTURE RISKS; SYMPATHETIC NERVES;

BONE; MACHINERY; OSTEOBLASTS; PHYSIOLOGY;

NOREPINEPHRINE;

AMINE OXIDASE (FLAVIN CONTAINING); BETA 2 MICROGLOBULIN; CALCITONIN RECEPTOR; CATECHOL METHYLTRANSFERASE; DEOXYPYRIDINOLINE; DOPAMINE BETA MONOOXYGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NORADRENALIN; NORADRENALIN TRANSPORTER; OSTEOCALCIN; REBOXETINE; TYROSINE 3 MONOOXYGENASE; UNCOUPLING PROTEIN 1; VESICULAR MONOAMINE TRANSPORTER;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MASS; BONE REMODELING; CELL DIFFERENTIATION; CHRONIC STRESS; CONTROLLED STUDY; FEMALE; FEMUR; HOMEOSTASIS; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORADRENALIN UPTAKE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPATHETIC NERVE; WILD TYPE;

ADHD; BONE REMODELING; GENE KNOCKOUT; MOUSE; NERVE; NEUROTRANSMITTER TRANSPORT; NOREPINEPHRINE TRANSPORTER; OSTEOBLASTS; SYMPATHETIC NERVOUS SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; BONE REMODELING; BONE RESORPTION; HUMANS; MICE; MICE, MUTANT STRAINS; MORPHOLINES; NEURONS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OSTEOCLASTS; PSYCHOMOTOR DISORDERS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84886883224     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.481309     Document Type: Article

References (53)

1. Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., Clement, K., Vaisse, C., and Karsenty, G. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514-520
2. Franquinho, F., Liz, M. A., Nunes, A. F., Neto, E., Lamghari, M., and Sousa, M. M. (2010) Neuropeptide Y and osteoblast differentiation. The balance between the neuro-osteogenic network and local control. FEBS J. 277, 3664-3674
3. Lee, N. J., and Herzog, H. (2009) NPY regulation of bone remodelling. Neuropeptides 43, 457-463
4. Fonseca, T. L., Jorgetti, V., Costa, C. C., Capelo, L. P., Covarrubias, A. E., Moulatlet, A. C., Teixeira, M. B., Hesse, E., Morethson, P., Beber, E. H., Freitas, F. R., Wang, C. C., Nonaka, K. O., Oliveira, R., Casarini, D. E., Zorn, T. M., Brum, P. C., and Gouveia, C. H. (2011) Double disruption of α2Aand α2C-adrenoceptors results in sympathetic hyperactivity and highbone- mass phenotype. J. Bone Miner. Res. 26, 591-603
5. Li, H., Fong, C., Chen, Y., Cai, G., and Yang, M. (2010) -Adrenergic signals regulate adipogenesis of mouse mesenchymal stem cells via cAMP/PKA pathway. Mol. Cell. Endocrinol. 323, 201-207
6. Aitken, S. J., Landao-Bassonga, E., Ralston, S. H., and Idris, A. I. (2009) β2-Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. Arch. Biochem. Biophys. 482, 96-103
7. Huang, H. H., Brennan, T. C., Muir, M. M., and Mason, R. S. (2009) Functional α1- and β2-adrenergic receptors in human osteoblasts. J. Cell. Physiol. 220, 267-275
8. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., and Karsenty, G. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317
9. Fu, L., Patel, M. S., Bradley, A., Wagner, E. F., and Karsenty, G. (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122, 803-815
10. Kajimura, D., Hinoi, E., Ferron, M., Kode, A., Riley, K. J., Zhou, B., Guo, X. E., and Karsenty, G. (2011) Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J. Exp. Med. 208, 841-851
11. Bonnet, N., Benhamou, C. L., Brunet-Imbault, B., Arlettaz, A., Horcajada, M. N., Richard, O., Vico, L., Collomp, K., and Courteix, D. (2005) Severe bone alterations under β2 agonist treatments. Bone mass, microarchitecture and strength analyses in female rats. Bone 37, 622-633
12. Bonnet, N., Benhamou, C. L., Beaupied, H., Laroche, N., Vico, L., Dolleans, E., and Courteix, D. (2007) Doping dose of salbutamol and exercise. Deleterious effect on cancellous and cortical bones in adult rats. J. Appl. Physiol. 102, 1502-1509
13. Kondo, H., and Togari, A. (2011) Continuous treatment with a low-dose β-agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif. Tissue Int. 88, 23-32
14. Horvath, G., Sutto, Z., Torbati, A., Conner, G. E., Salathe, M., and Wanner, A. (2003) Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L829-837
15. Ren, Z. G., Pörzgen, P. P., Youn, Y. H., and Sieber-Blum, M. (2003) Ubiquitous embryonic expression of the norepinephrine transporter. Dev. Neurosci. 25, 1-13
16. Keller, N. R., Diedrich, A., Appalsamy, M., Tuntrakool, S., Lonce, S., Finney, C., Caron, M. G., and Robertson, D. (2004) Norepinephrine transporter- deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity. Circulation 110, 1191-1196
17. Cryan, J. F., Mombereau, C., and Vassout, A. (2005) The tail suspension test as a model for assessing antidepressant activity. Review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 29, 571-625
18. Hahn, M. K., Mazei-Robison, M. S., and Blakely, R. D. (2005) Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol. Pharmacol. 68, 457-466
19. Hahn, M. K., Steele, A., Couch, R. S., Stein, M. A., and Krueger, J. J. (2009) Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder. Neuropharmacology 57, 694-701
20. Dziedzicka-Wasylewska, M., Faron-Górecka, A., Kusmider, M., Drozdowska, E., Rogóz, Z., Siwanowicz, J., Caron, M. G., and Bönisch, H. (2006) Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 31, 2424-2432
21. Pierroz, D. D., Bonnet, N., Bianchi, E. N., Bouxsein, M. L., Baldock, P. A., Rizzoli, R., and Ferrari, S. L. (2012) Deletion of -adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J. Bone miner. Res. 27, 1252-1262
22. Watkins, M. P., Norris, J. Y., Grimston, S. K., Zhang, X., Phipps, R. J., Ebetino, F. H., and Civitelli, R. (2012) Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice. Bone 51, 787-794
23. Joo, Y., Choi, K. M., Lee, Y. H., Kim, G., Lee, D. H., Roh, G. S., Kang, S. S., Cho, G. J., Choi, W. S., and Kim, H. J. (2009) Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex. Neurosci. Lett. 461, 121-125
24. Tjurmina, O. A., Armando, I., Saavedra, J. M., Goldstein, D. S., and Murphy, D. L. (2002) Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143, 4520-4526
25. Bonnet, N., Benhamou, C. L., Malaval, L., Goncalves, C., Vico, L., Eder, V., Pichon, C., and Courteix, D. (2008) Low dose -blocker prevents ovariectomy- induced bone loss in rats without affecting heart functions. J. Cell. Physiol. 217, 819-827
26. Bonnet, N., Laroche, N., Vico, L., Dolleans, E., Benhamou, C. L., and Courteix, D. (2006) Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J. Pharmacol. Exp. Ther. 318, 1118-1127
27. Kondo, H., Nifuji, A., Takeda, S., Ezura, Y., Rittling, S. R., Denhardt, D. T., Nakashima, K., Karsenty, G., and Noda, M. (2005) Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J. Biol. Chem. 280, 30192-30200
28. Sato, T., Arai, M., Goto, S., and Togari, A. (2010) Effects of propranolol on bone metabolism in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 334, 99-105
29. Wang, T. M., Hsu, J. F., Jee, W. S., and Matthews, J. L. (1993) Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone Miner. 20, 251-264
30. Gotoh, M., Mizuno, K., Ono, Y., and Takahashi, M. (2005) High blood pressure, bone-mineral loss and insulin resistance in women. Hypertens. Res. 28, 565-570
31. Graham, S., Hammond-Jones, D., Gamie, Z., Polyzois, I., Tsiridis, E., and Tsiridis, E. (2008) The effect of -blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing. Expert. Opin. Investig. Drugs 17, 1281-1299
32. Reid, I. R. (2008) Effects of -blockers on fracture risk. J. Musculoskelet. Neuronal Interact. 8, 105-110
33. Bonnet, N., Gadois, C., McCloskey, E., Lemineur, G., Lespessailles, E., Courteix, D., and Benhamou, C. L. (2007) Protective effect of β blockers in postmenopausal women. Influence on fractures, bone density, micro and macroarchitecture. Bone 40, 1209-1216
34. Cuscito, C., Colaianni, G., Tamma, R., Greco, G., Dell'Endice, S., Yuen, T., Sun, L., Zaidi, M., Di Benedetto, A., and Zallone, A. (2011) Adrenergic stimulation decreases osteoblast oxytocin synthesis. Ann. N.Y. Acad. Sci. 1237, 53-57
35. Tam, J., Trembovler, V., Di Marzo, V., Petrosino, S., Leo, G., Alexandrovich, A., Regev, E., Casap, N., Shteyer, A., Ledent, C., Karsak, M., Zimmer, A., Mechoulam, R., Yirmiya, R., Shohami, E., and Bab, I. (2008) The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J. 22, 285-294
36. Gilsbach, R., Faron-Górecka, A., Rogóz, Z., Brüss, M., Caron, M. G., Dziedzicka-Wasylewska, M., and Bönisch, H. (2006) Norepinephrine transporter knockout-induced up-regulation of brain 2A/C-adrenergic receptors. J. Neurochem. 96, 1111-1120
37. Tank, J., Schroeder, C., Diedrich, A., Szczech, E., Haertter, S., Sharma, A. M., Luft, F. C., and Jordan, J. (2003) Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation 107, 2949-2954
38. Carson, R. P., Diedrich, A., and Robertson, D. (2002) Autonomic control after blockade of the norepinephrine transporter. A model of orthostatic intolerance. J. Appl. Physiol. 93, 2192-2198
39. Bertram, D., Barrès, C., Cheng, Y., and Julien, C. (2000) Norepinephrine reuptake, baroreflex dynamics, and arterial pressure variability in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1257-1267
40. Veldhuis-Vlug, A. G., El Mahdiui, M., Endert, E., Heijboer, A. C., Fliers, E., and Bisschop, P. H. (2012) Bone resorption is increased in pheochromocytoma patients and normalizes following adrenalectomy. J. Clin. Endocrinol. Metab. 97, E2093-2097
41. Lin, S. F., Fan, X., Yeckel, C. W., Weinzimmer, D., Mulnix, T., Gallezot, J. D., Carson, R. E., Sherwin, R. S., and Ding, Y. S. (2012) Ex vivo and in vivo evaluation of the norepinephrine transporter ligand [11C]MRB for brown adipose tissue imaging. Nucl. Med. Biol. 39, 1081-1086
42. Schroeder, C., Adams, F., Boschmann, M., Tank, J., Haertter, S., Diedrich, A., Biaggioni, I., Luft, F. C., and Jordan, J. (2004) Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R851-856
43. Camporeale, A., Day, K. A., Ruff, D., Arsenault, J., Williams, D., and Kelsey, D. K. (2013) Profile of sexual and genitourinary treatment-emergent adverse events associated with atomoxetine treatment. A pooled analysis. Drug Saf. 36, 663-671
44. Hinojosa-Laborde, C., Chapa, I., Lange, D., and Haywood, J. R. (1999) Gender differences in sympathetic nervous system regulation. Clin. Exp. Pharmacol. Physiol. 26, 122-126
45. Hart, E. C., Charkoudian, N., Wallin, B. G., Curry, T. B., Eisenach, J. H., and Joyner, M. J. (2009) Sex differences in sympathetic neural-hemodynamic balance. Implications for human blood pressure regulation. Hypertension 53, 571-576
46. Moldovanova, I., Schroeder, C., Jacob, G., Hiemke, C., Diedrich, A., Luft, F. C., and Jordan, J. (2008) Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women. Hypertension 51, 1203-1209
47. Heal, D. J., Bristow, L. M., Hurst, E. M., Elliott, J. M., and Buckett, W. R. (1989) Sex-related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock. Br. J. Pharmacol. 97, 111-118
48. Campbell, J. P., Karolak, M. R., Ma, Y., Perrien, D. S., Masood-Campbell, S. K., Penner, N. L., Munoz, S. A., Zijlstra, A., Yang, X., Sterling, J. A., and Elefteriou, F. (2012) Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 10, e1001363
49. Johnston, C. C., Jr., and Longcope, C. (1990) Premenopausal bone loss. A risk factor for osteoporosis. N. Engl. J. Med. 323, 1271-1273
50. Matkovic, V., Jelic, T., Wardlaw, G. M., Ilich, J. Z., Goel, P. K., Wright, J. K., Andon, M. B., Smith, K. T., and Heaney, R. P. (1994) Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J. Clin. Investig. 93, 799-808
51. Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., Spencer, T., Ustun, T. B., Walters, E. E., and Zaslavsky, A. M. (2006) The prevalence and correlates of adult ADHD in the United States. Results from the National Comorbidity Survey Replication. Am. J. Psychiatry 163, 716-723
52. Simon, V., Czobor, P., B́lint, S., Mésźros, A., and Bitter, I. (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder. Meta-analysis. Br. J. Psychiatry 194, 204-211
53. Ziere, G., Dieleman, J. P., van der Cammen, T. J., Hofman, A., Pols, H. A., and Stricker, B. H. (2008) Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J. Clin. Psychopharmacol. 28, 411-417